Nasdaq
VRDN
Viridian Therapeutics, Inc.
- Health Care
- Listed 2014
- 1 day
- +6.8%
- 1 month
- +10.0%
- 1 year
- +30.9%
$22.51 · Mkt cap $2.32B
At the 6 Aug 2026 close
Nasdaq
Viridian Therapeutics, Inc.
$22.51 · Mkt cap $2.32B
At the 6 Aug 2026 close
Viridian Therapeutics, Inc. trades under the ticker VRDN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2014. Its market capitalisation is $2.32B. The last closing price was $22.51, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +30.9%, and +10.0% over the past month. Returns are price returns and exclude dividends.
This page exists because VRDN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.